Transition Guidance on OBBBA Domestic, Foreign Research Expensing Issued

The IRS on Thursday issued transitional guidance on the One Big Beautiful Bill’s (OBBBA) amendments to the treatment of research or experimental (R&E) expenditures under IRC § 174, clarifying how taxpayers can change their method of accounting or accounting periods to reflect the removal of the amortization requirement for domestic research. (Rev Proc 2025-28; IRB 2025-38, 8/28/2025)

Revenue Procedure 2025-28, issued August 28, addresses the separation of domestic and foreign R&E expenditures, new elections, transition relief, and accounting method changes.

To dig deeper, visit the original article on the Thomson Reuters blog.

  • Does UltraTax have any guidance on how to accelerate the amortization in 2025/2026 for the assets entered in 2022 - 2024?  Cannot find an article about it in Help & Support.  We are trying to do this for an S-Corp client now in 2025.

    Below is a link to CCH's article on how they're handling in ProSystem & Axcess:

    https://support.cch.com/oss/ml/kb/solution/000292710

  • Really wish the 174A option was available in Fixed Assets for assets place in service before 2025.  Only solution we are coming up with is transferring the 2022-2024 assets into a 2025 asset and using this box.